MARKHAM, ON, Feb. 26, 2013 /CNW/ - Nightingale Informatix Corporation ("Nightingale" or the "Company") (TSX-V: NGH), a cloud- based electronic medical record (EMR) software provider has had Nexia™ EMR v. 1.2 tested and certified
under the Drummond Group's Electronic Health Records Office of the
National Coordinator Authorized Certification Body (ONC-ACB) program.
This EHR software is compliant in accordance with the criteria adopted
by the Secretary of the U.S. Department of Health and Human Services.
"This is an important milestone for Nexia™, our next generation
product. We look forward to helping our clients achieve meaningful use
and qualify for incentive funds under ARRA. This certification is the
result of a lot of hard work by our dedicated team of designers,
developers and quality assurance testers," says Sam Chebib, President &
CEO, Nightingale Informatix Corporation.
Drummond Group's ONC-ACB certification program certifies that EHRs meet
the meaningful use criteria for either eligible provider or hospital
technology. In turn, healthcare providers using the EHR systems of
certified vendors are qualified to receive federal stimulus monies upon
demonstrating meaningful use of the technology - a key component of the
federal government's push to improve clinical care delivery through the
adoption and effective use of EHRs by U.S. healthcare providers.
Nexia™ EMR, which met the requirements for Meaningful Use Stage 1 is a
multi-tenanted, cloud-based application that was designed from the
ground-up to be as easy to use as possible with the goal of zero-based
"Right from the start, Nightingale has put an emphasis on the user
experience and has engaged client feedback at each step of the design
process," continues Chebib, "we have leveraged our 10 years of
experience in the market and the demands of thousands of our users to
develop a true next generation platform. The result is an application
that requires little to no training, runs on any operating system such
as Apple, Android and Microsoft and delivers the functions that our
clients want in an intuitive manner."
"Leveraging information technology for healthcare initiatives provides
the opportunity to deliver a high-level quality of care and efficiency
which essentially benefits and enhances the overall patient
experience," says Rik Drummond, CEO of the Drummond Group Inc. "We have
been testing software for more than a decade and will continue to
provide our extensive experience testing and certifying complex systems
for multiple industries, as well as ensuring interoperability and
security remain key components in the growing healthcare industry."
Nightingale anticipates that it will have achieved certification for
Meaningful Use Stage 2 by the end of 2013.
"This Complete EHR is 2011 Edition compliant and has been certified by an ONC-ACB in accordance with the
applicable certification criteria adopted by the Secretary of the U.S.
Department of Health and Human Services. This certification does not
represent an endorsement by the U.S. Department of Health and Human
Services or guarantee the receipt of incentive payments."
Vendor name: Nightingale Informatix Corporation. Date Certified:
01/24/2013. Product Version: Nexia™ EMR 1.2. Certification ID number:
01242013-1750-8. Clinical Quality Measures Certified: NQF0024, NQF0024,
NQF0028, NQF0038, NQF0041, NQF0043, NQF0061, NQF0064, NQF0421. Any
additional software relied upon to certify: none.
Nightingale is one of the fastest growing health care service and
software companies in North America and is recognized as an industry
leader in Web-based clinician and community based electronic medical
records (EMR) serving the needs of small primary care practices, multi-physician
outpatient clinics, and large scale regional health organizations and
networks. Nightingale's comprehensive service offering allows customers
to enhance patient care, increase revenue opportunities and optimize
operations. Nightingale is continuously innovating and enhancing its
services to meet the needs of its growing and diverse customer base.
Nightingale - Healthcare connected. www.nightingalemd.com
About Drummond Group Inc.
Drummond Group Inc. is a global software test and certification lab that
serves a wide range of vertical industries. In healthcare, Drummond
Group tests and certifies Controlled Substance Ordering Systems (CSOS),
Electronic Prescription of Controlled Substances (EPCS) software and
processes, and Electronic Health Records (EHRs) - designating the
trusted test lab as the only third-party certifier of all three
initiatives designed to move the industry toward a digital future.
Founded in 1999, and accredited for the Office of the National
Coordinator HIT Certification Program as an Authorized Certification
Body (ACB) and an Authorized Test Lab (ATL), Drummond Group continues
to build upon its deep experience and expertise necessary to deliver
reliable and cost-effective services. For more information, please
visit http://www.drummondgroup.com or email DGI@drummondgroup.com.
Forward Looking Statement
This press release contains "forward-looking statements" respecting the
issuance and cancellation of securities of the Company within the
meaning of applicable Canadian securities legislation. Generally,
forward-looking statements can be identified by the use of forward-
looking terminology such as "plans", "expects" or "does not expect",
"budget", "scheduled", "estimates", "forecasts", "intends",
"anticipates" or "does not anticipate", or "believes", or variations of
such words and phrases or state that certain actions, events or results
"may" ,"could", "would", "might", "occur" or "be achieved".
Forward-looking statements are subject to known and unknown risks,
uncertainties and other factors that may cause the actual results,
level of activity, performance or achievements of Nightingale to be
materially different from those expressed or implied by such
forward-looking statements, including but not limited to: risks related
to the speculative nature of the medical software industry, which is
affected by numerous factors beyond Nightingale's control; the ability
of Nightingale to successfully secure customer contracts and the timing
of securing such contracts; the ability of Nightingale to complete and
successfully integrate its acquisitions on an accretive basis,
Nightingale's access to debt and capital facilities, including
compliance with current debt arrangements; the existence of present and
possible future government regulation; the significant competition that
exists in the medical software industry; the early stage of
Nightingale's business, and risks associated with early stage
companies, including uncertainty of revenues, markets and profitability
and the need to raise additional funding. All material assumptions
used in making forward-looking statements are based on management's
knowledge of current business conditions and expectations of future
business conditions and trends. Certain material factors or assumptions
applied by management in making forward-looking statements, include
without limitation, factors and assumptions regarding future trends in
healthcare spending, economic conditions affecting Nightingale and
North American economies; Nightingale's ability to continue to fund its
business, rates of customer defaults, relationships with, and payments
to lenders, as well as Nightingale's operating cost structure.
Although Nightingale has attempted to identify important factors that
could cause actual results to differ materially from those contained in
forward-looking statements, there may be other factors that cause
results not to be as anticipated, estimated or intended. There can be
no assurance that such statements will prove to be accurate, as actual
results and future events could differ materially from those
anticipated in such statements. Accordingly, readers should not place
undue reliance on forward-looking statements. Nightingale does not
undertake to update any forward-looking statements that are
incorporated by reference herein, except in accordance with applicable
securities laws. Further information on Nightingale Informatix
Corporation is available at www.sedar.com.
Neither the TSX Venture Exchange nor its Regulation Services Provider
(as that term is defined in the policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of this release.
SOURCE: Nightingale Informatix Corporation
For further information:
For further information about Nightingale, contact:
Marketing Communications Manager
Nightingale Informatix Corporation
Tel: 416-815-0700 ext. 273